نتایج جستجو برای: mycophenolate mofetil
تعداد نتایج: 3651 فیلتر نتایج به سال:
Patients with heritable and idiopathic PVOD have few therapeutic options. On suspicion of immune dysregulation, methylprednisolone or oral prednisolone then mycophenolate mofetil was trialled in three cases, resulting clinical improvement/stability.https://bit.ly/376mwR9
Background and objective The rate of end-stage renal disease from lupus nephritis has not declined, in spite of recent advances in therapeutics, such as mycophenolate mofetil (MMF). To provide insight into rates of the clinical outcomes in current practice after biopsy-proven lupus nephritis, we used a prospective cohort of the patients with newly diagnosed lupus nephritis, treated with MMF and...
Atherosclerosis is a form of chronic inflammation in which endothelial cell dysfunction, fibroproliferative process, oxidative stress and inflammatory cell activation are linked to plaque development and destabilization. T-lymphocytes also play a key role in pathogenesis of atherosclerosis. As a consequence, the suggested concept that modulation of an immunological response could be an appropri...
Correspondence: Helena Sá [email protected] Hospital da Universidade de Coimbra. Praceta Mota Pinto 3000-075 Coimbra. Portugal INTRODUCTION Mycophenolate mofetil (MMF), the first pharmaceutical prodrug of mycophenolic acid (MPA) that received approval for human clinical use, has been utilised in solid organ transplantation since 1995, particularly in kidney transplantation. MMF launchin...
BACKGROUND/AIMS Mycophenolate mofetil (MMF) has been increasingly used for the treatment of lupus nephritis (LN). The aim of this study was to examine the efficacy and safety of MMF used with low doses of corticosteroids as maintenance therapy in patients with LN. METHODS The study covered 35 patients, most of them with proliferative types of LN (5 WHO class III, 26 class IV), while 1 had cla...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید